UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 226

Sortiert nach

Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2

Molecules (Basel, Switzerland), 2020-09, Vol.25 (19), p.4459

2020

Link zum Volltext

Verfügbarkeit prüfen

The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings

Inflammopharmacology, 2013-06, Vol.21 (3), p.201-232

2013

Link zum Volltext

Verfügbarkeit prüfen

Potent Chlorambucil-Platinum(IV) Prodrugs

International journal of molecular sciences, 2022-09, Vol.23 (18), p.10471

2022

Link zum Volltext

Verfügbarkeit prüfen

Bioactive Platinum(IV) Complexes Incorporating Halogenated Phenylacetates

Molecules (Basel, Switzerland), 2022-10, Vol.27 (20), p.7120

2022

Link zum Volltext

Verfügbarkeit prüfen

Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2181

2024

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and Predictive Value of Liquid Biopsy-Derived Androgen Receptor Variant 7 (AR-V7) in Prostate Cancer: A Systematic Review and Meta-Analysis

Frontiers in oncology, 2022-03, Vol.12, p.868031-868031

2022

Link zum Volltext

Verfügbarkeit prüfen

Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells

Scientific reports, 2022-09, Vol.12 (1), p.16159-16159, Article 16159

2022

Link zum Volltext

Verfügbarkeit prüfen

Human Group IIA Phospholipase A2—Three Decades on from Its Discovery

Molecules (Basel, Switzerland), 2021-11, Vol.26 (23), p.7267

2021

Link zum Volltext

Verfügbarkeit prüfen

Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity

Pharmaceutics, 2022-04, Vol.14 (4), p.787

2022

Link zum Volltext

Verfügbarkeit prüfen

Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents

Cancers, 2023-04, Vol.15 (9), p.2460

2023

Link zum Volltext

Verfügbarkeit prüfen

Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy

Cancers, 2022-03, Vol.14 (7), p.1669

2022

Link zum Volltext

Verfügbarkeit prüfen

New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use

International journal of cancer, 2014-06, Vol.134 (11), p.2523-2533

2014

Link zum Volltext

Verfügbarkeit prüfen

The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?

Prostate cancer, 2020, Vol.2020, p.7938280-16

2020

Link zum Volltext

Verfügbarkeit prüfen

Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate Cancer

Clinical cancer research, 2008-12, Vol.14 (24), p.8070-8079

2008

Link zum Volltext

Verfügbarkeit prüfen

Anti-cancer potential of synergistic phytochemical combinations is influenced by the genetic profile of prostate cancer cell lines

Frontiers in nutrition (Lausanne), 2023-03, Vol.10, p.1119274-1119274

2023

Link zum Volltext

Verfügbarkeit prüfen

Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations

Biochemical pharmacology, 2010-04, Vol.79 (8), p.1156-1164

2010

Link zum Volltext

Verfügbarkeit prüfen

Oncogenic action of phospholipase A2 in prostate cancer

Cancer letters, 2006-08, Vol.240 (1), p.9-16

2006

Link zum Volltext

Verfügbarkeit prüfen

A Bifunctional Role for Group IIA Secreted Phospholipase A2 in Human Rheumatoid Fibroblast-like Synoviocyte Arachidonic Acid Metabolism

The Journal of biological chemistry, 2011-01, Vol.286 (4), p.2492-2503

2011

Link zum Volltext

Verfügbarkeit prüfen

Limitations of drug concentrations used in cell culture studies for understanding clinical responses of NSAIDs

Inflammopharmacology, 2021-10, Vol.29 (5), p.1261-1278

2021

Link zum Volltext

Verfügbarkeit prüfen

Human TERT promoter mutations as a prognostic biomarker in glioma

Journal of cancer research and clinical oncology, 2021-04, Vol.147 (4), p.1007-1017

2021

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers in immune checkpoint inhibition therapy for cancer patients: what is the role of lymphocyte subsets and PD1/PD-L1?

Translational medicine communications, 2019-02, Vol.4 (1), p.1-13, Article 2

2019

Link zum Volltext

Verfügbarkeit prüfen

Antibacterial actions of secreted phospholipases A2. Review

Biochimica et biophysica acta, 2008-01, Vol.1781 (1-2), p.1-9

2008

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of action of paracetamol

American journal of therapeutics, 2005-01, Vol.12 (1), p.46

2005

Link zum Volltext

Verfügbarkeit prüfen

Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer

Cancers, 2024-07, Vol.16 (14), p.2544

2024

Link zum Volltext

Verfügbarkeit prüfen

Honorary Professor Garry Graham

Inflammopharmacology, 2021-10, Vol.29 (5), p.1255-1259

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(218)
Mit Volltextzugriff
(208)

Publikationsform

Artikel
(224)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(128)
Life Sciences & Biomedicine
(120)
Humans
(106)
Cardiovascular System & Cardiology
(57)
Cardiac & Cardiovascular Systems
(56)
Heart Failure
(54)
Male
(42)
Stroke Volume
(32)
Heart Failure - Drug Therapy
(30)
Female
(29)
Aged
(26)
Animals
(19)
Dapagliflozin
(17)
Middle Aged
(17)
Biological And Medical Sciences
(16)
Benzhydryl Compounds - Therapeutic Use
(15)
Cosmic Microwave Background
(15)
Glucosides - Therapeutic Use
(15)
Cancer
(14)
Heart Failure - Complications
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Structural and Functional Aspects of Targeting the Secreted Human Group IIA Phospholipase A2

The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings

Potent Chlorambucil-Platinum(IV) Prodrugs

Bioactive Platinum(IV) Complexes Incorporating Halogenated Phenylacetates

Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity

Prognostic and Predictive Value of Liquid Biopsy-Derived Androgen Receptor Variant 7 (AR-V7) in Prostate Cancer: A Systematic Review and Meta-Analysis

Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells

Human Group IIA Phospholipase A2—Three Decades on from Its Discovery

Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity

Versatile Platinum(IV) Prodrugs of Naproxen and Acemetacin as Chemo-Anti-Inflammatory Agents

Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy

New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use

The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?

Cytosolic Phospholipase A2-α: A Potential Therapeutic Target for Prostate Cancer

Anti-cancer potential of synergistic phytochemical combinations is influenced by the genetic profile of prostate cancer cell lines

Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations

Oncogenic action of phospholipase A2 in prostate cancer

A Bifunctional Role for Group IIA Secreted Phospholipase A2 in Human Rheumatoid Fibroblast-like Synoviocyte Arachidonic Acid Metabolism

Limitations of drug concentrations used in cell culture studies for understanding clinical responses of NSAIDs

Human TERT promoter mutations as a prognostic biomarker in glioma

Biomarkers in immune checkpoint inhibition therapy for cancer patients: what is the role of lymphocyte subsets and PD1/PD-L1?

Antibacterial actions of secreted phospholipases A2. Review

Mechanism of action of paracetamol

Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer

Honorary Professor Garry Graham

Suchergebnisse filtern